Which has preferable valuation and earnings, AVNT or ASPI?

Avient has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Avient $3.26B 1.03 $81.90M $1.72 21.36 ASP Isotopes $23.85M 32.65 -$175.09M -$2.08 N/A

Is AVNT or ASPI more profitable?

Avient has a net margin of 4.81% compared to ASP Isotopes' net margin of -644.40%. Avient's return on equity of 11.11% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets Avient 4.81% 11.11% 4.40% ASP Isotopes -644.40% -112.46% -53.36%

Does the media refer more to AVNT or ASPI?

In the previous week, ASP Isotopes had 3 more articles in the media than Avient. MarketBeat recorded 4 mentions for ASP Isotopes and 1 mentions for Avient. Avient's average media sentiment score of 0.85 beat ASP Isotopes' score of 0.50 indicating that Avient is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Avient 0 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive ASP Isotopes 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Is ASPI or CC more profitable?

Chemours has a net margin of -6.82% compared to ASP Isotopes' net margin of -644.40%. Chemours' return on equity of 52.49% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets ASP Isotopes -644.40% -112.46% -53.36% Chemours -6.82% 52.49% 1.78%

Does the media prefer ASPI or CC?

In the previous week, Chemours had 4 more articles in the media than ASP Isotopes. MarketBeat recorded 8 mentions for Chemours and 4 mentions for ASP Isotopes. ASP Isotopes' average media sentiment score of 0.50 beat Chemours' score of 0.28 indicating that ASP Isotopes is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Chemours 2 Very Positive mention(s) 2 Positive mention(s) 1 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has higher valuation & earnings, ASPI or NGVT?

Ingevity has higher revenue and earnings than ASP Isotopes. Ingevity is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio ASP Isotopes $23.85M 32.65 -$175.09M -$2.08 N/A Ingevity $1.18B 2.18 -$167.10M -$3.55 N/A

Is ASPI or NGVT more profitable?

Ingevity has a net margin of -10.55% compared to ASP Isotopes' net margin of -644.40%. Ingevity's return on equity of 207.82% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets ASP Isotopes -644.40% -112.46% -53.36% Ingevity -10.55% 207.82% 9.70%

Does the media refer more to ASPI or NGVT?

In the previous week, ASP Isotopes had 1 more articles in the media than Ingevity. MarketBeat recorded 4 mentions for ASP Isotopes and 3 mentions for Ingevity. Ingevity's average media sentiment score of 0.95 beat ASP Isotopes' score of 0.50 indicating that Ingevity is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Ingevity 1 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor ASPI or PCT?

In the previous week, PureCycle Technologies had 1 more articles in the media than ASP Isotopes. MarketBeat recorded 5 mentions for PureCycle Technologies and 4 mentions for ASP Isotopes. ASP Isotopes' average media sentiment score of 0.50 beat PureCycle Technologies' score of 0.19 indicating that ASP Isotopes is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment ASP Isotopes 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral PureCycle Technologies 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

Which has higher earnings and valuation, ECVT or ASPI?

Ecovyst has higher revenue and earnings than ASP Isotopes. Ecovyst is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Ecovyst $723.50M 1.84 -$71.13M -$0.55 N/A ASP Isotopes $23.85M 32.65 -$175.09M -$2.08 N/A

Is ECVT or ASPI more profitable?

Ecovyst has a net margin of -7.71% compared to ASP Isotopes' net margin of -644.40%. Ecovyst's return on equity of 11.58% beat ASP Isotopes' return on equity. Company Net Margins Return on Equity Return on Assets Ecovyst -7.71% 11.58% 4.76% ASP Isotopes -644.40% -112.46% -53.36%

Does the media favor ECVT or ASPI?

In the previous week, ASP Isotopes had 1 more articles in the media than Ecovyst. MarketBeat recorded 4 mentions for ASP Isotopes and 3 mentions for Ecovyst. ASP Isotopes' average media sentiment score of 0.50 beat Ecovyst's score of -0.50 indicating that ASP Isotopes is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Ecovyst 0 Very Positive mention(s) 0 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Negative ASP Isotopes 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral

ASP Isotopes (ASPI) Competitors

$6.19 +0.02 (+0.26%)

As of 11:10 AM Eastern

Compare

ASPI vs. AVNT, CC, NGVT, PCT, and ECVT

Should you buy ASP Isotopes stock or one of its competitors? MarketBeat compares ASP Isotopes with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with ASP Isotopes include Avient (AVNT), Chemours (CC), Ingevity (NGVT), PureCycle Technologies (PCT), and Ecovyst (ECVT). These companies are all part of the "chemicals" industry.

How does ASP Isotopes compare to Avient?

Avient (NYSE:AVNT) and ASP Isotopes (NASDAQ:ASPI) are both basic materials companies, but which is the better business? We will compare the two companies based on the strength of their dividends, analyst recommendations, valuation, profitability, earnings, media sentiment, institutional ownership and risk.

95.5% of Avient shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 0.9% of Avient shares are owned by company insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

In the previous week, ASP Isotopes had 3 more articles in the media than Avient. MarketBeat recorded 4 mentions for ASP Isotopes and 1 mentions for Avient. Avient's average media sentiment score of 0.85 beat ASP Isotopes' score of 0.50 indicating that Avient is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Avient	0 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
ASP Isotopes	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

Avient has higher revenue and earnings than ASP Isotopes. ASP Isotopes is trading at a lower price-to-earnings ratio than Avient, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Avient	$3.26B	1.03	$81.90M	$1.72	21.36
ASP Isotopes	$23.85M	32.65	-$175.09M	-$2.08	N/A

Avient has a net margin of 4.81% compared to ASP Isotopes' net margin of -644.40%. Avient's return on equity of 11.11% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Avient	4.81%	11.11%	4.40%
ASP Isotopes	-644.40%	-112.46%	-53.36%

Avient presently has a consensus price target of $45.71, indicating a potential upside of 24.42%. ASP Isotopes has a consensus price target of $13.00, indicating a potential upside of 110.15%. Given ASP Isotopes' higher possible upside, analysts plainly believe ASP Isotopes is more favorable than Avient.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Avient	0 Sell rating(s)	4 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.43
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Avient has a beta of 1.28, suggesting that its share price is 28% more volatile than the broader market. Comparatively, ASP Isotopes has a beta of 3.42, suggesting that its share price is 242% more volatile than the broader market.

Summary

Avient beats ASP Isotopes on 11 of the 16 factors compared between the two stocks.

How does ASP Isotopes compare to Chemours?

ASP Isotopes (NASDAQ:ASPI) and Chemours (NYSE:CC) are both basic materials companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, valuation, institutional ownership, dividends, earnings, profitability, media sentiment and risk.

16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 76.3% of Chemours shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by company insiders. Comparatively, 0.9% of Chemours shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

Chemours has a net margin of -6.82% compared to ASP Isotopes' net margin of -644.40%. Chemours' return on equity of 52.49% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
Chemours	-6.82%	52.49%	1.78%

ASP Isotopes has higher earnings, but lower revenue than Chemours. Chemours is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	32.65	-$175.09M	-$2.08	N/A
Chemours	$5.82B	0.50	-$386M	-$2.64	N/A

ASP Isotopes has a beta of 3.42, meaning that its share price is 242% more volatile than the broader market. Comparatively, Chemours has a beta of 1.4, meaning that its share price is 40% more volatile than the broader market.

In the previous week, Chemours had 4 more articles in the media than ASP Isotopes. MarketBeat recorded 8 mentions for Chemours and 4 mentions for ASP Isotopes. ASP Isotopes' average media sentiment score of 0.50 beat Chemours' score of 0.28 indicating that ASP Isotopes is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ASP Isotopes	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Chemours	2 Very Positive mention(s)	2 Positive mention(s)	1 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Neutral

ASP Isotopes currently has a consensus target price of $13.00, suggesting a potential upside of 110.15%. Chemours has a consensus target price of $24.60, suggesting a potential upside of 25.95%. Given ASP Isotopes' higher possible upside, analysts plainly believe ASP Isotopes is more favorable than Chemours.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Chemours	1 Sell rating(s)	5 Hold rating(s)	6 Buy rating(s)	0 Strong Buy rating(s)	2.42

Summary

ASP Isotopes and Chemours tied by winning 8 of the 16 factors compared between the two stocks.

How does ASP Isotopes compare to Ingevity?

ASP Isotopes (NASDAQ:ASPI) and Ingevity (NYSE:NGVT) are both basic materials companies, but which is the superior investment? We will compare the two companies based on the strength of their earnings, media sentiment, valuation, dividends, risk, institutional ownership, analyst recommendations and profitability.

Ingevity has higher revenue and earnings than ASP Isotopes. Ingevity is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	32.65	-$175.09M	-$2.08	N/A
Ingevity	$1.18B	2.18	-$167.10M	-$3.55	N/A

Ingevity has a net margin of -10.55% compared to ASP Isotopes' net margin of -644.40%. Ingevity's return on equity of 207.82% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
Ingevity	-10.55%	207.82%	9.70%

ASP Isotopes has a beta of 3.42, meaning that its stock price is 242% more volatile than the broader market. Comparatively, Ingevity has a beta of 1.18, meaning that its stock price is 18% more volatile than the broader market.

16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 91.6% of Ingevity shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by insiders. Comparatively, 0.9% of Ingevity shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

ASP Isotopes currently has a consensus price target of $13.00, suggesting a potential upside of 110.15%. Ingevity has a consensus price target of $80.00, suggesting a potential upside of 8.45%. Given ASP Isotopes' stronger consensus rating and higher possible upside, analysts plainly believe ASP Isotopes is more favorable than Ingevity.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
Ingevity	1 Sell rating(s)	2 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.20

In the previous week, ASP Isotopes had 1 more articles in the media than Ingevity. MarketBeat recorded 4 mentions for ASP Isotopes and 3 mentions for Ingevity. Ingevity's average media sentiment score of 0.95 beat ASP Isotopes' score of 0.50 indicating that Ingevity is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ASP Isotopes	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Ingevity	1 Very Positive mention(s)	1 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

ASP Isotopes beats Ingevity on 8 of the 15 factors compared between the two stocks.

How does ASP Isotopes compare to PureCycle Technologies?

ASP Isotopes (NASDAQ:ASPI) and PureCycle Technologies (NASDAQ:PCT) are both small-cap chemicals companies, but which is the better business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, earnings, media sentiment, risk, institutional ownership, valuation and profitability.

ASP Isotopes has a net margin of -644.40% compared to PureCycle Technologies' net margin of -2,062.36%. ASP Isotopes' return on equity of -112.46% beat PureCycle Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
ASP Isotopes	-644.40%	-112.46%	-53.36%
PureCycle Technologies	-2,062.36%	-393.01%	-22.56%

ASP Isotopes presently has a consensus price target of $13.00, indicating a potential upside of 110.15%. PureCycle Technologies has a consensus price target of $12.25, indicating a potential upside of 65.88%. Given ASP Isotopes' higher possible upside, equities research analysts clearly believe ASP Isotopes is more favorable than PureCycle Technologies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33
PureCycle Technologies	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	2.50

In the previous week, PureCycle Technologies had 1 more articles in the media than ASP Isotopes. MarketBeat recorded 5 mentions for PureCycle Technologies and 4 mentions for ASP Isotopes. ASP Isotopes' average media sentiment score of 0.50 beat PureCycle Technologies' score of 0.19 indicating that ASP Isotopes is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
ASP Isotopes	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
PureCycle Technologies	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

ASP Isotopes has higher revenue and earnings than PureCycle Technologies. PureCycle Technologies is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
ASP Isotopes	$23.85M	32.65	-$175.09M	-$2.08	N/A
PureCycle Technologies	$8.35M	159.96	-$182.57M	-$1.47	N/A

16.8% of ASP Isotopes shares are held by institutional investors. Comparatively, 63.0% of PureCycle Technologies shares are held by institutional investors. 14.4% of ASP Isotopes shares are held by insiders. Comparatively, 18.8% of PureCycle Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

ASP Isotopes has a beta of 3.42, meaning that its share price is 242% more volatile than the broader market. Comparatively, PureCycle Technologies has a beta of 2.48, meaning that its share price is 148% more volatile than the broader market.

Summary

ASP Isotopes beats PureCycle Technologies on 9 of the 17 factors compared between the two stocks.

How does ASP Isotopes compare to Ecovyst?

Ecovyst (NYSE:ECVT) and ASP Isotopes (NASDAQ:ASPI) are both small-cap basic materials companies, but which is the better business? We will compare the two businesses based on the strength of their institutional ownership, analyst recommendations, valuation, profitability, risk, dividends, media sentiment and earnings.

Ecovyst has a net margin of -7.71% compared to ASP Isotopes' net margin of -644.40%. Ecovyst's return on equity of 11.58% beat ASP Isotopes' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Ecovyst	-7.71%	11.58%	4.76%
ASP Isotopes	-644.40%	-112.46%	-53.36%

Ecovyst has a beta of 1.08, suggesting that its stock price is 8% more volatile than the broader market. Comparatively, ASP Isotopes has a beta of 3.42, suggesting that its stock price is 242% more volatile than the broader market.

In the previous week, ASP Isotopes had 1 more articles in the media than Ecovyst. MarketBeat recorded 4 mentions for ASP Isotopes and 3 mentions for Ecovyst. ASP Isotopes' average media sentiment score of 0.50 beat Ecovyst's score of -0.50 indicating that ASP Isotopes is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Ecovyst	0 Very Positive mention(s)	0 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Negative
ASP Isotopes	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral

86.7% of Ecovyst shares are owned by institutional investors. Comparatively, 16.8% of ASP Isotopes shares are owned by institutional investors. 1.8% of Ecovyst shares are owned by insiders. Comparatively, 14.4% of ASP Isotopes shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Ecovyst has higher revenue and earnings than ASP Isotopes. Ecovyst is trading at a lower price-to-earnings ratio than ASP Isotopes, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Ecovyst	$723.50M	1.84	-$71.13M	-$0.55	N/A
ASP Isotopes	$23.85M	32.65	-$175.09M	-$2.08	N/A

Ecovyst currently has a consensus target price of $13.90, indicating a potential upside of 14.12%. ASP Isotopes has a consensus target price of $13.00, indicating a potential upside of 110.15%. Given ASP Isotopes' higher probable upside, analysts plainly believe ASP Isotopes is more favorable than Ecovyst.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Ecovyst	1 Sell rating(s)	1 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.50
ASP Isotopes	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

Summary

Ecovyst beats ASP Isotopes on 9 of the 16 factors compared between the two stocks.

Get ASP Isotopes News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ASPI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

ASPI vs. The Competition

Export

Metric	ASP Isotopes	CHEM Industry	Materials Sector	NASDAQ Exchange
Market Cap	$779.57M	$12.30B	$4.54B	$12.33B
Dividend Yield	N/A	2.53%	5.03%	6.11%
P/E Ratio	-2.98	35.63	22.59	24.20
Price / Sales	32.65	1.92	5,419.35	101.54
Price / Cash	N/A	12.06	24.12	36.93
Price / Book	2.61	1.90	8.76	6.42
Net Income	-$175.09M	$171.68M	$157.33M	$336.87M
7 Day Performance	-15.03%	-3.79%	-3.16%	0.94%
1 Month Performance	-20.49%	-7.31%	-7.79%	-0.53%
1 Year Performance	-16.41%	26.74%	47.53%	27.96%

ASP Isotopes Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
ASPI ASP Isotopes	1.7781 of 5 stars	$6.19 +0.3%	$13.00 +110.2%	-16.6%	$779.57M	$23.85M	N/A	76	Gap Up
AVNT Avient	4.5343 of 5 stars	$37.31 -0.9%	$45.71 +22.5%	+14.8%	$3.45B	$3.26B	21.69	9,000
CC Chemours	3.7212 of 5 stars	$21.47 -1.4%	$24.60 +14.6%	+76.5%	$3.27B	$5.81B	N/A	5,700
NGVT Ingevity	2.023 of 5 stars	$72.66 -1.0%	$80.00 +10.1%	+76.3%	$2.55B	$1.17B	N/A	1,500	Analyst Downgrade High Trading Volume
PCT PureCycle Technologies	2.2433 of 5 stars	$8.34 -4.1%	$12.25 +46.9%	-43.1%	$1.57B	$8.35M	N/A	120	Gap Down

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:ASPI) was last updated on 6/29/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

ASP Isotopes (ASPI) Competitors

ASPI vs. AVNT, CC, NGVT, PCT, and ECVT

How does ASP Isotopes compare to Avient?

Summary

How does ASP Isotopes compare to Chemours?

Summary

How does ASP Isotopes compare to Ingevity?

Summary

How does ASP Isotopes compare to PureCycle Technologies?

Summary

How does ASP Isotopes compare to Ecovyst?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASPI vs. The Competition

ASP Isotopes Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

ASP Isotopes (ASPI) Competitors

ASPI vs. AVNT, CC, NGVT, PCT, and ECVT

How does ASP Isotopes compare to Avient?

Do institutionals & insiders believe in AVNT or ASPI?

Does the media refer more to AVNT or ASPI?

Which has preferable valuation and earnings, AVNT or ASPI?

Is AVNT or ASPI more profitable?

Do analysts rate AVNT or ASPI?

Which has more volatility & risk, AVNT or ASPI?

Summary

How does ASP Isotopes compare to Chemours?

Do institutionals and insiders hold more shares of ASPI or CC?

Is ASPI or CC more profitable?

Which has better earnings and valuation, ASPI or CC?

Which has more volatility and risk, ASPI or CC?

Does the media prefer ASPI or CC?

Do analysts recommend ASPI or CC?

Summary

How does ASP Isotopes compare to Ingevity?

Which has higher valuation & earnings, ASPI or NGVT?

Is ASPI or NGVT more profitable?

Which has more risk and volatility, ASPI or NGVT?

Do institutionals & insiders hold more shares of ASPI or NGVT?

Do analysts prefer ASPI or NGVT?

Does the media refer more to ASPI or NGVT?

Summary

How does ASP Isotopes compare to PureCycle Technologies?

Is ASPI or PCT more profitable?

Do analysts recommend ASPI or PCT?

Does the media favor ASPI or PCT?

Which has stronger valuation and earnings, ASPI or PCT?

Do institutionals and insiders have more ownership in ASPI or PCT?

Which has more risk and volatility, ASPI or PCT?

Summary

How does ASP Isotopes compare to Ecovyst?

Is ECVT or ASPI more profitable?

Which has more risk & volatility, ECVT or ASPI?

Does the media favor ECVT or ASPI?

Do insiders & institutionals believe in ECVT or ASPI?

Which has higher earnings and valuation, ECVT or ASPI?

Do analysts prefer ECVT or ASPI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

ASPI vs. The Competition

ASP Isotopes Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools